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Abstract
Excitotoxic neuronal death induced by high concentrations of glutamate is a pathological event common to multiple
acute or chronic neurodegenerative diseases. Excitotoxicity is mediated through overactivation of the N-Methyl-D-
aspartate type of ionotropic glutamate receptors (NMDARs). Physiological stimulation of NMDARs triggers their
endocytosis from the neuronal surface, inducing synaptic activity and survival. However almost nothing is known
about the internalization of overactivated NMDARs and their interacting proteins, and how this endocytic process is
connected with neuronal death has been poorly explored. Kinase D-interacting substrate of 220 kDa (Kidins220), also
known as ankyrin repeat-rich membrane spanning (ARMS), is a component of NMDAR complexes essential for
neuronal viability by the control of ERK activation. Here we have investigated Kidins220 endocytosis induced by
NMDAR overstimulation and the participation of this internalization step in the molecular mechanisms of
excitotoxicity. We show that excitotoxicity induces Kidins220 and GluN1 traffic to the Golgi apparatus (GA) before
Kidins220 is degraded by the protease calpain. We also find that excitotoxicity triggers an early activation of Rap1-
GTPase followed by its inactivation. Kidins220 excitotoxic endocytosis and subsequent calpain-mediated
downregulation governs this late inactivation of Rap1 that is associated to decreases in ERK activity preceding
neuronal death. Furthermore, we identify the molecular mechanisms involved in the excitotoxic shutoff of Kidins220/
Rap1/ERK prosurvival cascade that depends on calpain processing of Rap1-activation complexes. Our data fit in a
model where Kidins220 targeting to the GA during early excitotoxicity would facilitate Rap1 activation and subsequent
stimulation of ERK. At later times, activation of Golgi-associated calpain, would promote the degradation of GA-
targeted Kidins220 and two additional components of the specific Rap1 activation complex, PDZ-GEF1, and S-SCAM. In
this way, late excitotoxicity would turn off Rap1/ERK cascade and compromise neuronal survival.
Introduction
Overstimulation of the N-Methyl-D-aspartate type of
ionotropic glutamate receptors (NMDARs) triggers exci-
totoxicity, a type of neuronal death that contributes to
neurodegeneration in acute neuropathologies (stroke,
traumatic brain injury, and epilepsy) and chronic neuro-
degenerative diseases (Alzheimer’s, Parkinson’s, or Hun-
tington’s)1. By contrast, activation of NMDARs with
physiological concentrations of glutamate is fundamental
to neuronal synaptic activity, playing key roles in plasti-
city, learning and memory2, as well as neuronal survival
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through activation of extracellular signal-regulated kinase
(ERK)3.
Functional NMDARs are heteromeric complexes com-
posed primarily of two obligatory GluN1 subunits and
two GluN2 or GluN3 subunits4. Diversity in NMDARs
properties is mainly conferred by GluN2A and GluN2B
subunits4. Function and signaling of NMDARs relie on
their spatial and temporal distribution at the neuronal
surface where they undergo endocytosis after exposure to
nonpathological concentrations of their co-agonists glu-
tamate and glycine5–9. Physiological NMDAR inter-
nalization is mediated by clathrin/dynamin-dependent
endocytosis to Rab5-positive early endosomes9,10.
Carboxy-terminal motifs in GluN2A/B subunits direct
endocytosed NMDARs to recycling endosomes and back
to the surface, while conserved sequences near the jux-
tamembrane region of GluN1 and GluN2 drive receptors
toward late endosomes and degradation8. NMDAR over-
activation triggers endocytic processes in neurons pre-
ceding death in cellular models of excitotoxicity11 or
cerebral ischemia12. However, very little is known about
how NMDAR overstimulation affects its own inter-
nalization. A recent publication has shown the excitotoxic
induction of GluN2B-containing NMDARs endocytosis in
primary neurons and the relationship of this endocytic
process with neuronal death13. Despite these data, the
molecular mechanisms downstream endocytosis of over-
activated NMDARs and their connection to excitotoxicity
remain unexplored.
Kinase D-interacting substrate of 220 kDa
(Kidins22014), also known as ankyrin repeat-rich mem-
brane spanning (ARMS15), is an effector of NMDAR
signaling essential for neuronal viability by the control of
ERK16,17. Silencing of Kidins220 reduces basal ERK
activity and neuronal survival, additionally potentiating
NMDAR-mediated excitotoxicity16,17. Transient cerebral
ischemia and in vitro excitoxicity decrease Kidins220
levels16. This downregulation contributes to neuronal
death and primarily depends on Kidins220 rapid cleavage
by the Ca2+-dependent protease calpain, activated by high
Ca2+ influx through overactivated NMDARs16,17.
Remarkably, GluN2 and GluN1 subunits are also down-
regulated by excitotoxicity18,19. Considerable evidences
support the impact of downregulation of these compo-
nents on neuronal survival16–19. There are no proofs
however of Kidins220 endocytosis induced by NMDAR
stimulation or the participation of this internalization in
the mechanisms of excitotoxicity.
Here we find that excitotoxicity induces Kidins220 and
GluN1 internalization. Kidins220 is targeted to the Golgi
apparatus (GA) through a Rab5-positive endosomal
compartment at time points when no calpain degradation
has occurred yet, indicating that Kidins220 proteolysis
might start once at the GA. We also show that Kidins220
excitotoxic endocytosis and subsequent downregulation
governs inactivation of the small GTP-ase Rap1 that
ultimately controls decreases in ERK activity preceding
neuronal death. Furthermore, we identify the molecular
mechanisms involved in the excitotoxic shutoff of
Kidins220/Rap1/ERKs prosurvival cascade that depends
on calpain processing of Rap1-activation complexes.
Materials and methods
Materials and chemicals
N-Methyl-D-aspartate (NMDA), glycine, cytosine β-D-
arabinofuranoside (AraC), poly-L-lysine, L-laminin,
cycloheximide (CHX), and Optiprep were acquired from
Sigma Co. (St. Louis, MO, USA). Calpain I (μ-calpain) and
calpain inhibitor CiIII were acquired from Calbiochem-
Merck Bioscience (Darmstadt, Germany), antagonist 2-
amino-phosphopentanoic acid (DL-AP5) from Tocris
(Bristol, UK) and Rap1 inhibitor GGTI289 from Millipore
Corporation (Billerica, MA, USA). Lipofectamine 2000
and Glutamax were purchased from Thermo Fisher Sci-
entific (Rockford, IL, USA). ECL Western Lighting Che-
miluminesence Reagent Plus was purchased from Perkin-
Elmer Life Sciences (Boston, MA, USA), and the BCA
reagent and Pierce Cell Surface Protein Isolation Kit were
purchased from Pierce Thermo Fisher Scientific
(Rockford).
Antibodies
Kidins220 C-terminal rabbit polyclonal antiserum
(Kidins220) was generated as described14, using as
immunogen a 17 amino-acid peptide from the protein C-
terminal end. This antibody was used for all immuno-
fluorescence and immunoblot analysis unless otherwise
indicated. For immunodetection of Kidins220 in electron
microscopy analysis the same purified C-terminal rabbit
polyclonal antibody obtained from Abcam (Cambridge,
UK) was used. A novel Kidins220 extracellular region
(Kid-ER) antibody was generated after rabbit immuniza-
tion with a peptide (C-LVFAFTVDTNLAIA) containing
an extracellular region of the protein (see scheme in
Supplementary Fig. 1A). Kid-ER antiserum was purified
after protein A-sepharose binding, elution, neutralization,
and dialysis by standard procedures before its application
for immunofluorescence analysis. The specificity of this
new antibody was first validated preabsorbing Kid-ER
with the immunizing peptide and performing immuno-
blot analysis of neuronal lysates (Supplementary Fig. 1B).
Kid-ER immunoblot specificity was also confirmed after
silencing Kidins220 in cultured neurons (Supplementary
Fig. 1C). Control experiments using immunizing peptide-
competed antiserum showed Kid-ER immunofluorescence
staining was specific (Supplementary Fig. 1D). Rabbit
polyclonal antibodies recognizing active phospho-Thr202/
Tyr204 extracellular signal-regulated kinase (pERK-1/2)
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were from Cell Signaling Technology (Beverly, MA, USA).
Rabbit polyclonal antibody recognizing PDZ-GEF1 was
generated in N.M.'s laboratory, and those against neuro-
nal specific enolase (NSE) and Rap1 GTP-ase were from
ICN Biomedicals (Costa Mesa, CA, USA) and Millipore
Corporation (Billerica, MA, USA), respectively. Rabbit
polyclonal antibody recognizing H-, K-, and N-Ras and
monoclonal antibodies against Shc and Golgi matrix
protein of 130 kDa (GM130) were acquired from BD
Transduction Laboratories (San Jose, CA, USA). Mono-
clonal antibodies against β-actin and spectrin, and rabbit
polyclonal antibody recognizing α-, β-, and γ-isoforms of
S-SCAM were purchased from Sigma Co. (St. Louis, MO,
USA). Mouse monoclonal antibodies specific for α−1,
β−1, and β−2 isoforms of syntrophin, GluN1, and
hemagglutinin epitope were purchased from Affinity
BioReagents (Golden, CO, USA), Pharmingen (San Diego,
CA, USA) and Covance (Berkeley, CA, USA), respectively.
Rabbit polyclonal antibodies recognizing total ERK-1/2,
C3G, Grb2, SOS, Crk, and FRS2 and were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Horseradish peroxidase-conjugated and Alexa-Fluor-488,
-546, and -647-coupled antibodies were purchased from
General Electric (Fairfield, CT, USA) and Molecular
Probes (Thermo Fisher Scientific; Rockford, IL, USA).
Cell culture and treatment of primary cortical neurons
Neuronal cultures were prepared from cerebral cortex
of 19-day-old Wistar rat embryos, as we have previously
described16,19. Rats were obtained from the animal care
facility at the Instituto de Investigaciones Biomédicas
“Alberto Sols” (CSIC-UAM, Madrid, Spain). Animal
procedures were approved by the ethical committee from
the CSIC and performed in compliance with European
Directive 2010/63/EU. Neurons were used after 10 days
in vitro (DIV) for immunofluorescence and DIV14 for
biochemical assays. Neurons were pretreated or treated
for different times as indicated with the following con-
centrations of reactives: 100 μM NMDA, 10 μM glycine,
200 μM DL-AP5, 10 μM CiIII, 200 μM CHX, 15 μM
Lactacystin, 100 μM zVAD, and 10 μM GGTI298. Exci-
totoxicity was induced by treatment with the NMDAR co-
agonists NMDA and glycine. Unless otherwise stated
inhibitors were added 1 h before treatment with NMDA/
glycine and remained in the culture media for the dura-
tion of the experiment.
Preparation of protein extracts, immunoblot analysis, and
immunoprecipitation
Preparation of protein extracts and immunoprecipita-
tion were performed as described16. Equal amounts of
total lysates or equivalent volumes of immunocomplexes
were resolved on SDS-PAGE and analyzed by immuno-
blot. Membranes were incubated with different primary
and secondary antibodies and immunoreactive bands
were detected by ECL (Perkin-Elmer Life Sciences, Bos-
ton, MA, USA).
Plasmids and transfection of neurons
Golgi-GFP, Rab5-GFP, and HA-Rap1 constructs were
kindly provided by Professors M. Zerial (Max Panck
Institute of Molecular Cell Biology and Genetics, Dresden,
Germany), V. Malhotra (Centre for Genomic Regulation,
Barcelona, Spain), and P. Crespo (Instituto de Biomedi-
cina y Biotecnología de Cantabria, Santander, Spain),
respectively. Primary cortical neurons DIV8 were trans-
fected with Lipofectamine 2000 reagent. DNA–liposome
complexes were prepared in Neurobasal Medium
(Thermo Fisher Scientific; Rockford, IL, USA) and added
to the cultures. Two hours later, liposomes were removed,
and neurons were fed with conditioned medium and
maintained in culture for 48 h before experimental
treatments.
Cloning Rap1A mutants in a lentiviral vector for
neurospecific expression
Lentiviral vectors for neurospecific expression of HA-
Rap1A and HA-Rap1A-V12 were generated from their
corresponding pMT2HA-Rap1A and pMT2HA-Rap1A-
V12 plasmids as follows. Both Rap1A-tagged sequences
were amplified using forward (5′-CGC GGA TCC TTA
ATG GCT TAC CCA TAC GAT GT-3′) and reverse (5′-
CAT TAA GCG GCC GCC ACT TTC CAA TTA GGC
AAC A-3′) primers containing BamH1 and Not1
restriction sites, respectively (bold). Once digested, PCR
products were subcloned in a lentiviral vector bearing
human Synapsin promoter (SYNpr) SYNpr-DsRed-
SYNpr-GFP20, where DsRed sequence had been pre-
viously depleted after digestion with BamHI and NotI.
Constructs were sequenced using an Applied Biosystems
automated DNA sequencer (Thermo Fisher Scientific;
Rockford, IL, USA).
Lentiviral infection of neuronal cultures
Lentiviral transduction was performed as previously
described, adding lentiviral particles to the growing media
of DIV8 neurons and left for 6 additional days16.
Cell surface protein biotinylation assays
DIV10 untreated neurons or stimulated with NMDA for
the indicated times were placed on ice, washed two times
with ice-cold PBS containing 1mM CaCl2 and 0.5 mM
MgCl2 (PBS/Ca
2+/Mg2+), and surface biotinylated with
the Pierce Cell Surface Protein Isolation Kit (Pierce,
Thermo Fisher Scientific; Rockford, IL, USA). Briefly, EZ-
Link Sulfo-NHS-SS-Biotin was freshly dissolved at
0.7 mg/ml in ice-cold PBS/Ca2+/Mg2+ and added to the
cultures. Incubation proceeded for 12 min at 4 °C with
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constant shaking. Then, biotin solution was removed and
dishes were blocked by washing three times with PBS/Ca2
+/Mg2+ containing 0.1% BSA and two times with ice-cold
PBS/Ca2+/Mg2+ to eliminate the excess of biotin reagent
that was not efficiently incorporated to the cell surface.
Finally neurons were lysed in RIPA buffer containing
protease and phosphatase inhibitors16, and solubilised by
rotating 1 h at 4 °C. Nuclear and cellular debris were
removed by centrifugation at 12,000 rpm for 5 min at 4 °C
and supernatants were precipitated with 100 μl of Ultra-
Link NeutrAvidin slurry (Pierce, Thermo Fisher Scien-
tific) for 2 h at 4 °C. Beads were washed twice in RIPA
buffer containing 500 mM NaCl and once in RIPA buffer
containing 150mM NaCl. Beads were resuspended in
100 μl of sample buffer and resolved on SDS-PAGE.
Internalization of biotinylated surface proteins
To analyze internalization of cell surface proteins,
untreated DIV10 neurons were placed on ice and washed
twice with ice-cold PBS/Ca2+/Mg2+. Biotin was added as
explained for cell surface biotinylation assays, left for
15 min at 4 °C, removed and cultures were blocked with
ice-cold PBS/Ca2+/Mg2+ containing 0.1% BSA. After
washing unbound biotin twice with PBS/Ca2+/Mg2+,
conditioned growth medium was added back to neurons
that were returned to the incubator for 30 min at 37 °C.
Cultures were then treated with NMDA for 10min or left
unstimulated. Biotin surface cleavage was performed by
placing the dishes on ice and incubating with ice-cold
cleaving buffer (50 mM glutathione in 75mM NaCl,
10 mM EDTA, 1% BSA, and 0.075M NaOH) twice for
10min at 4 °C with constant shaking. Finally neurons
were washed four times in ice-cold PBS/Ca2+/Mg2+, lysed
in RIPA buffer and supernatants were precipitated with
UltraLink NeutrAvidin beads for immunoblot analysis as
indicated above for cell surface biotinylation assays.
Immunofluorescence and confocal microscopy
For immunofluorescence neurons grown on coverslips
were fixed for 15min in 4% paraformaldehyde in PBS
containing 4% sucrose at 37 °C. After blocking, cells were
incubated at room temperature for 2 h with the corre-
sponding antibody diluted in 0.05% saponin in PBS.
Immunoreactivity was detected with suitable fluorophore-
conjugated secondary antibody before mounting on slides
with Prolong (Thermo Fisher Scientific; Rockford, IL,
USA). Images are single sections of a z-series acquiring
each channel in a sequential mode using an inverted Zeiss
LSM710 confocal microscope with a ×63/1.40 Plan-
Apochromatic objective. Pictures were processed with
ZEN 2009 light Edition (Carl Zeiss MicroImaging) and
Adobe CS3 Extended (Adobe Systems Inc.) software.
Pearson correlation coefficient (PCC) was assed using
ImageJ (v1.47d, NIH, Bethesda, MD, USA).
For surface localization, DIV10 cortical neurons were
treated with NMDA for 30min, immediately fixed in 4%
paraformaldehyde in PBS at 4 °C for 4 min. Blocking with
2% BSA and 2% donkey serum for 30min was followed by
incubation with Kid-ER overnight at 4 °C, application of
secondary antibody and mounting as above. Quantifica-
tion of fluorescence intensity was carried out using ImageJ
software. Neurons were thresholded by gray value at a
level close to 50% of the dynamic range. Background noise
from these images was negligible. Average fluorescence
was quantified after selecting a dendrite segment in the
differential interference contrast image of untreated or
NMDA-treated neurons.
Immunoelectron microscopy and quantification
Subcellular localization of Kidins220 in cortical cultures
in control conditions and after treatment with NMDA for
10, 30, and 60min was analyzed using the preembedding
immunogold method21. Briefly, DIV10 neurons were fixed
using 4% paraformaldehyde plus 0.2% glutaraldehyde plus
15% picric acid in 0.1 phosphate buffer (PB), pH7.4,
during 4 h. Cultures were then incubated at room tem-
perature for 1 h in 10% normal goat serum (NGS) diluted
in TBS and for 24 h in anti-Kidins220 antibody (Abcam,
Cambridge, UK) at a final protein concentration of
1–2 μg/ml diluted in TBS containing 1% NGS. After
several washes in TBS, sections were incubated for 3 h in
goat anti-rabbit IgG coupled to 1.4 nm gold (Nanoprobes)
diluted 1:100 in TBS containing 1% NGS. The cultures
were then washed in PBS and postfixed in 1% glutar-
aldehyde diluted in the same buffer for 10min. They were
washed in double-distilled water, followed by silver
enhancement of the gold particles with an HQ silver kit
(Nanoprobes). This processing was followed by treatment
with osmium tetraoxide (1% in 0.1M PB), block-staining
with uranyl acetate, dehydration in graded series of
ethanol, and embedding in Durcupan (Fluka) resin. Cor-
tical cultures were cut at 70–90 nm on an ultramicrotome
(Reichert Ultracut E; Leica) and collected on 200-mesh
nickel grids. Staining was performed on drops of 1%
aqueous uranyl acetate followed by Reynolds’s lead citrate.
Ultrastructural analyses were performed in a Jeol-1010
electron microscope. Immunogold labeling was evaluated
quantitatively to test differences in Kidins220 distribution
in control conditions and after treatment with NMDA.
Quantification was performed on nine ultrathin sections
randomly chosen from each of the two different cover-
slips. Electron microscopic serial ultrathin sections were
cut close to the surface of each block. Randomly selected
areas were captured at a final magnification of ×40,000 for
each experimental group. In each reference area, the
numbers of gold particles attached to the plasma mem-
brane of cell bodies and neurites, and membranous
intracellular compartments were counted. Then the
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percentage of immunoparticles positive for Kidins220 was
calculated in control conditions and after treatment with
NMDA. The background labeling was evaluated in the
same way calculating the density of Kidins220 over
mitochondria, nuclei, and empty resin.
Subcellular fractionation
Subcellular fractionation was performed using Optiprep
(60% iodixanol; Axis Shield PoC AS, Oslo, Norway)
density gradient centrifugation following the protocol
described by Arevalo et al.22 with slight modifications.
Cortical neurons (DIV14) were cracked in breaking buffer
(250 mM sucrose, 10 mM HEPES pH 7.4, 1 mM EDTA,
1 mM MgOAc and protease and phosphatase inhibitors).
A cell homogenizer (Isobiotec Heidelberg, Germany) of
0.5 ml volume was used with a tungsten carbide ball of
7.988 mm diameter. Samples were centrifuged at
3,000 rpm for 5 min at 4 °C, and the obtained postnuclear
supernatant was then subjected to a second centrifugation
for 30min at 13,900 rpm at 4 °C to get the membrane
fraction. Membranes were resuspended in 50mM Tris-HCl
pH 7.5 and adjusted to 25% iodixanol, loaded at the bottom
of a SW40Ti ultracentrifuge tube and overlaid with 20%,
15%, 10%, and 5% iodixanol, all of them prepared in 50mM
Tris-HCl pH 7.5 containing protease and phosphatase
inhibitors. Gradients were centrifuged at 27,000 rpm for
18 h at 4 °C using a SW40Ti rotor (Beckman, Fullerton,
CA). After gradient centrifugation, 25 fractions were col-
lected from top to bottom of the tube, and equal volumes
from each fraction were analyzed by immunoblot.
Pull-down assays
Rap1-GTP pull-down assays were performed using the
Rap1 Activation Assay Kit (Millipore Corporation; Bill-
erica, MA, USA) according manufacture’s specifications.
Briefly, untreated neurons or stimulated with NMDA for
the indicated periods of time were washed in TBS and
lysed in RBL buffer (50 mM Tris.HCl, pH 7.4, 500mM
NaCl, 1% NP40, 2.5 mM MgCl2, and 5% glycerol) con-
taining protease inhibitors. The samples were centrifuged
for 5 min at 4 °C and 14,000 rpm and the supernatant was
collected and incubated for 1 h at 4 °C with 20 μg GST-
RalGDS-RBD immobilized on glutathione-sepharose
beads. Beads were washed three times with RLB and
resuspended in Laemmli reducing sample buffer, and
GTP-Rap1 was detected by immunobloting with an anti-
Rap1 polyclonal antibody. Ras-GTP pull-down assays
were performed as above but using GST-Raf1-RBD
immobilized on glutathione-sepharose beads and detec-
tion with a pan-Ras antibody.
Quantitative and statistical analysis
Immunoblot signals were quantified by densitometric
analysis (NIH Image), normalized using NSE and
expressed relative to values obtained in their respective
controls. Results are shown as mean ± standard error of
the mean of 3–8 independent experiments. Statistical
significance was determined by unpaired Student’s t-test.
A p-value smaller than 0.05 was considered statistically
significant: *p < 0.05, **p < 0.01, ***p < 0.001.
Results
Kidins220 and GluN1 are internalized early during
excitotoxicity through mechanisms dependent on NMDAR
overactivation
The effects of excitotoxicity on endocytosis of NMDARs
and associated proteins, including Kidins22016, are largely
unknown. We therefore tested whether excitotoxicity
could induce Kidins220 internalization. Cultured cortical
neurons were exposed to excitotoxic concentrations of
NMDA (100 μM) and the co-agonist glycine (10 μM), a
treatment referred as “NMDA”. In untreated neurons,
endogenous Kidins220 immunostaining showed a more
intense signal at the periphery and vesicles of neuronal
somas and extensions (Fig. 1a). NMDA treatment chan-
ged Kidins220 localization, appearing after 30 min of sti-
mulation along vesicular and semicircular structures
reminiscent of membranous intracellular compartments.
At later times Kidins220 intensity decreased gradually,
concentrated closer to the nucleus with a highly spotted
pattern (Fig. 1a). Analysis of GluN1, the obligatory
NMDAR subunit1, revealed a highly vesiculated staining
partially overlapping that of Kidins220 at the cell surface
in untreated neurons, as previously observed16. Excito-
toxicity induced GluN1 redistribution and accumulation
with Kidins220 in intracellular membranous structures
(Fig. 1b). PCC analysis revealed that 95% of neurons dis-
played values ≥0.5 at 1 h of treatment, demonstrating a
high degree of colocalization (Fig. 1c, d).
Next, we labeled plasma membrane proteins by surface
biotinylation and compared levels of biotinylated
Kidins220 to total protein in the whole lysates. Specific
isolation of surface proteins was assessed by the lack of
signal for cytosolic protein kinase D (Fig. 1e). NMDA
treatment reduced Kidins220 at the cell surface from
10min (Fig. 1e), finding a 48 ± 4% decrease upon 30 min
of NMDAR overactivation, while corresponding total
levels remained unchanged (Fig. 1e, f). Surface GluN1
decreased with similar kinetics (Fig. 1e). The decrease of
Kidins220 and GluN1 surface content was not due to
downregulation induced by excitotoxicity16,19, since this
decline occurs later in time. Indeed, incubation with
NMDA for 60min was required to produce a slight
reduction on GluN1 and Kidins220 in total lysates
(Fig. 1e).
To further confirm Kidin220 internalization, we labeled
cell-surface proteins with biotin before 10min NMDA
stimulation. Then, we cleaved biotin from surface
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Fig. 1 (See legend on next page.)
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proteins and checked internalized biotinylated Kidins220
and GluN1. Surface biotinylated Kidins220 and GluN1
decreased by NMDA treatment while internalized pro-
teins increased (Fig. 1g). For Kidins220, this short NMDA
treatment induced a 45 ± 4% decrease in surface levels and
a 178 ± 10% increase in the internalized protein (Fig. 1h).
Next, we preincubated neurons with the selective
NMDAR antagonist DL-AP5 before adding NMDA for
1 h. Immunostaining and biotinylation assays demon-
strated that Kidins220 internalization depended on
NMDAR overactivation (Fig. 1i, j). GluN1 internalization
was also hampered by DL-AP5 pretreatment. Thus,
excitotoxicity induces internalization of NMDAR-
complexes containing Kidins220 from the plasma mem-
brane to intracellular compartments.
Excitotoxicity depletes Kidins220 from the plasma
membrane and mediates its recruitment towards the Golgi
apparatus
To characterize ultrastructurally the compartment/s
where Kidins220 was internalized, we performed immu-
nogold labeling and electron microscopy analysis of
neurons after NMDAR overstimulation (Fig. 2). Before
NMDA addition, Kidins220 was abundant in cell bodies
and dendrites, along plasma membrane (arrows) and at
intracellular membranous compartments (crossed arrows;
Fig. 2a, A1–A3, and Fig. 2b). A high concentration of
immunogold particles distributed in patches within neu-
ronal extensions (Fig. 2a, A3). In the cell body, Kidins220
was mainly associated with the rough endoplasmic reti-
culum (Fig. 2a, A1). Only 10min after NMDARs over-
stimulation, Kidins220 localization changed significantly
towards intracellular sites (Fig. 2a, B1–B3, and Fig. 2b),
decreasing along plasma membrane (Fig. 2a, B1–B2,
arrows). In cell bodies, particles accumulated beneath
plasma membrane or were associated with intracellular
vesicles (Fig. 2a, B1–B2, arrowheads). A dramatic reduc-
tion of immunoparticles within dendrites was detected at
this time-point (Fig. 2a, B3). After 30min of treatment,
Kidins220 concentrated intracellularly at the soma (Fig. 2a,
C1–C3, and Fig. 2b), in vesicles, cisternae, and GA frag-
ments (Fig. 2a, C1–C2, arrowheads), while signal along
neuronal extensions was almost lost. Stimulation for
60min increased this effect (Fig. 2a, D1–D3, and Fig. 2b).
These results suggest that excitotoxicity provokes a major
internalization of Kidins220 from the somatic plasma
membrane and dendritic locations towards the GA.
To further assess Kidins220 decrease at the plasma
membrane, we developed an antibody recognizing its
extracellular region (Kid-ER, see scheme and validation in
Supplementary Fig. 1). Inmunofluorescence of neurons
treated for 30min with NMDA detected a decrease in
Kidins220 that was significant at processes (Fig. 2c, d),
correlating with results obtained by electron microscopy,
and strengthening the notion of Kidins220 severe recruit-
ment from the surface of dendritic compartment to intra-
cellular somatic locations under excitotoxic conditions.
Next, we examined Kidins220 internalization to the GA
by confocal microscopy. While Kidins220 was hardly
detected at the GA in untreated neurons, its colocaliza-
tion with the cis-Golgi marker GM130 increased
significantly after 30 min and 1 h of NMDAR over-
stimulation (Fig. 3a). No neurons presented a PCC ≥ 0.5
(mean value 0.24 ± 0.02) under basal conditions while,
after 60 min of NMDA incubation, 93.4% of neurons
showed a PCC ≥ 0.5 (mean value 0.64 ± 0.02) (Fig. 3b, c).
Transfection of neurons with the transmembrane domain
of Golgi protein mannosidase II fused to GFP (Golgi-GFP)
(see figure on previous page)
Fig. 1 Internalization of Kidins220 and GluN1 by NMDA-induced excitotoxicity. a Immunofluorescence of Kidins220 in cortical neurons left
untreated or treated with high concentrations of NMDA (100 µM) and the co-agonist glycine (10 µM) (from now referred as NMDA) for the indicated
times. Nuclei were stained with DAPI. Merge confocal microscopy images and magnifications corresponding to the boxed areas are depicted. Scale
bar: 10 μm. b Kidins220 and GluN1 colocalization in control and NMDA-stimulated neurons analyzed by immunostaining and confocal microscopy.
Scale bars: 10 μm. c, d Percentage of cells displaying colocalization and mean values of Pearson correlation coefficient (PCC), respectively, calculated
in single optical sections to quantify Kidins220 and GluN1 colocalization. Data shown are the means ± s.e.m of three independent experiments after
counting n= 20–30 neurons. e Cultured cortical neurons were treated with NMDA for the indicated times and then surface proteins labeled with
biotin. The abundance of Kidins220 and GluN1 in total lysates (TL) and in the cell surface was determined by immunoblot. Cytosolic Protein kinase D
(PKD) inmunoblot signal was used as a negative control of surface proteins and neuronal specific enolase (NSE) as loading control. f Quantification of
the effect of 30 min NMDA treatment on Kidins220 surface localization. Data represented are the means ± s.e.m of four independent experiments,
and are expressed relative to values obtained in nonstimulated cells arbitrary assigned a value of 100%. ***p < 0.001, Student’s t-test. g To analyze
internalization, surface proteins of cultured cortical neurons were labeled before addition of NMDA for 10 min. The amount of Kidins220 and GluN1 in
TL or internalized after cleavage of surface biotin, was assessed by immunoblot. As a control, cell surface labeling at this NMDA time point was
performed as in e, processed and quantified in parallel. h Quantification of the effect of 10 min NMDA treatment on Kidins220 total levels, surface
localization, and internalization. Data represented are the means ± s.e.m of three independent experiments, and are expressed relative to values
obtained in nonstimulated cells arbitrary assigned a value of 100%. *p < 0.05, **p < 0.01, Student’s t-test. i, j Confocal microscopy images, surface
biotinylation assays, and immunoblot analysis to study dependence of Kidins220 location on NMDAR overactivation. Neurons were preincubated
with NMDAR noncompetitive antagonist DL-AP5 (200 μM) before NMDA stimulation for 60 min. Representative results out of three independent
experiments are shown. Scale bar: 10 μm
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rendered similar results (Supplementary Fig. 2). Excito-
toxicity in our in vitro model induced a high degree of GA
fragmentation (Fig. 3a), in agreement with other reports23.
Importantly, preincubation with DL-AP5 prevented
Kidins220/GM130 colocalization, as well as fission of
Golgi cisternae induced by NMDA (Fig. 3). Preincubation
with the inhibitor of de novo protein biosynthesis CHX
before NMDA addition for 30min showed that
Kidins220/GM130 colocalization was not affected (Fig.
3d–f). These data indicate that Kidins220 increase at the
GA is due to recruitment of previously synthesized pro-
tein to this organelle during excitotoxicity. Kidins220 is
relocated from the cell surface and other internal com-
partments to the GA, where it remains recruited during
excitotoxic fragmentation of this organelle. Because
Kidins220 is detected here by a C-terminal antibody, a
region rapidly lost in an excitotoxic- and calpain-
dependent manner16,17, our results suggest these locali-
zation changes take place before its extensive excitotoxic
calpain degradation.
Excitotoxicity increases Kidins220 presence at Rab5-
endocytic compartment
Targeting of cargos from the plasma membrane to the
GA can occur through different endosomal compart-
ments24. Physiological internalization of NMDARs is
mediated by Rab5, a GTP-ase linked to early endosomes9.
We explored whether NMDAR overstimulation similarly
induced endocytosis of Kidins220 to a Rab5-positive
compartment and found that NMDA treatment increased
their colocalization (Fig. 4a). PCC values increased from
0.58 ± 0.01 in unstimulated neurons to 0.67 ± 0.01 after
only 10min of NMDA treatment, Rab5 signal still over-
lapping with that of Kidins220 after 60 min (Fig. 4b, c).
These results were confirmed by overstimulating
NMDARs in neurons transfected with a Rab5-GFP con-
struct (Fig. 4d). The PCC obtained in basal conditions
(0.55 ± 0.023) increased to mean values of 0.65 ± 0.04 and
0.72 ± 0.02 after 10 and 30min of NMDA treatment,
respectively (Fig. 4e, f). These results suggest that Rab5
may participate in Kidins220 traffic from the plasma
membrane through early endosomes to the GA during
excitotoxicity.
Excitotoxicity induces Kidins220-mediated Rap1 activation
and association to the Golgi apparatus at early times
Kidins220 mediates the activation of Rap1, a GTP-ase
involved in ERK stimulation, downstream neurotrophin
receptor endocytosis22,25,26. Since Kidins220 contributes
to early ERK activation after NMDAR over-
stimulation16,17, we wondered whether Rap1 was activated
and participated in this process. Pull-down assays from
lysates of cultures exposed to excitotoxicity showed a
transient Rap1 activation that was maximal between
30min and 1 h of treatment, and decreased significantly
below control levels at 6 h (Fig. 5a, b). Interestingly, Rap1
activity returned to the control levels from 2 to 4 h of
NMDA incubation along with a considerable reduction in
Kidins220 and phospho-ERK-1/2 (pERK-1/2) (Fig. 5). In
fact, complete time-course analysis of ERK-1/2 activity
during excitotoxicity revealed a complex activation/inac-
tivation kinetics, similar to that observed for Rap1.
NMDAR overstimulation produced a maximum ERK-1/2
activation after 30 min that was maintained for the next
2 h, decreasing progressively later (Fig. 5c, d). We also
analyzed Ras activity since it is induced by physiological
activation of NMDARs and could be also controlling ERK
stimulation27–30. In contrast to Rap1, Ras underwent a
very rapid excitotoxic inactivation (Supplementary Fig. 3).
Altogether, these results suggested Kidins220 participa-
tion in the transient activation of Rap1/ERK pathway in
excitotoxicity.
Because maximal Rap1 activation after NMDAR over-
stimulation is coincident with Kidins220 internalization to
the GA, we hypothesized that Kidins220 could contribute
to Rap1 activation at this organelle. Analysis of Rap1
localization showed that it did not localize at the GA in
untreated neurons but a partial association was induced
after 1 h of NMDA treatment (Fig. 6a). To further study
Kidins220 and Rap1 association with early endosomes or
(see figure on previous page)
Fig. 2 Kidins220 is reduced at the dendritic compartment and enriched in somatic intracellular compartments after NMDARs
overstimulation. a Kidins220 subcellular localization was analyzed in neuronal cultures untreated (A1–A3) and treated with NMDA for different
periods of time (B1–B3, C1–C3, D1–D3) by electron microscopy using a preembedding immunogold method. Representative images are shown.
Panels named with subscripts 1 and 2 show immunoparticles present in cell bodies while subscript 3 is used when dendrites are depicted. Plasma
membrane (arrows), rough endoplasmic reticulum (crossed arrows), and intracellular vesicles and Golgi apparatus (both as arrowheads) are indicated.
Scale bars: 0.5 μm. b Quantification of Kidins220-immunoparticles present at the plasma membrane and intracellular sites along NMDA stimulation,
both in soma (Top graph) and dendrites (Bottom graph). Two different coverslips of each condition from two independent experiments were used,
and nine ultrathin sections were randomly chosen from each coverslip for quantification purposes. c Representative images of differential
interference contrast (DIC) microscopy and confocal microscopy immunostainig with a novel antibody recognizing Kidins220 extracellular region
(Kid-ER) in control or 30 min NMDA-treated, fixed and nonpermeabilized neurons. White boxes indicate magnified dendritic regions. Scale bars,
10 μm and 3 μm. d Quantification of mean intensity of dendritic Kidins220 surface staining in untreated neurons versus those NMDA-treated. Data are
represented as means ± s.e.m of three independent experiments after quantifying n ≥ 18 neurons for each condition. ***p < 0.001, Student’s t-test
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Fig. 3 Excitotoxicity induces Kidins220 translocation to the Golgi apparatus. a Coimmunostaining of Kidins220 and the Golgi apparatus marker
GM130 in neurons treated with NMDA for the indicated times in the absence or presence of the NMDAR antagonist DL-AP5 (200 μM, 60 min). Nuclei
were stained with DAPI. Merge confocal microscopy images and magnifications corresponding to the boxed areas are depicted. Scale bar: 10 μm. b,
c Percentage of cells displaying colocalization of Kidins220 and GM130 and mean Pearson correlation coefficient (PCC) values, respectively, after
60 min of NMDA treatment, calculated in single optical sections obtained from the different conditions. d Merged magnified images of Kidins220 and
GM130 coimmunofluorescence in neurons preincubated with cycloheximide (CHX; 200 μM, 240min) before NMDA stimulation for 60 min. e, f
Percentage of cells displaying colocalization of Kidins220 and GM130 and mean PCC values were calculated as above. Data shown are the means ± s.
e.m of three independent experiments after counting n= 20–40 neurons. **p < 0.01, ***p < 0.001, Student’s t-test
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GA, we fractionated neuronal membranes. Immunoblot
analysis of gradient fractions interfaces (I1–I4) showed
Kidins220, GluN1, and Rap1 enriched in I1 together with
the endosomal marker Rab5 in control neurons (Fig. 6b).
NMDA treatment for 30min induced a shift of Kidin220,
Rap1, and Rab5 towards heavier fractions also containing
GM130 (Fig. 6b). Although some GM130 was present in
I1 in untreated neurons, excitotoxicity increased its signal
in this lighter fraction, together with that in I2, probably
indicative of GA initial vesiculation. These results show
that excitotoxicity affects Kidins220, Rap1, Rab5, and
GM130 mobility in the gradients, provoking their broader
distribution and comigration in similar compartments.
Together with results in Fig. 5, these data suggested that
Rap1 translocation to the GA could be connected to its
activation. To explore this possibility, neurons were
transfected with HA-Rap1A or a constitutively active
mutant HA-Rap1A-V12, together with Golgi-GFP. HA-
Rap1A colocalization with Golgi-GFP significantly
increased after 1 h of NMDA treatment (Fig. 6c, e, f).
However, active HA-Rap1A-V12 already localized at the
GA in an 87% of untreated cells reaching a 100% in
NMDA-treated neurons (Fig. 6d–f). Endogenous
Kidins220 also colocalized with HA-Rap1 or HA-Rap1-
V12 at the GA after 1 h of NMDARs overstimulation
(Supplementary Fig. 4). Together, these results show that
excitotoxicity promotes the association of Rap1 and
Kidins220 to the GA, and support that active Rap1
associates to this compartment.
The decrease in Kidins220 levels registered at late
excitotoxicity times could contribute to Rap1 inactivation
and consequently to that of ERK. To check this hypoth-
esis, we transduced cultured neurons with lentiviruses
bearing a shRNA for Kidins220 silencing (ShK) or a
(see figure on previous page)
Fig. 4 NMDAR overstimulation increases Kidins220 localization at early endosomes. a Coimmunostaining of Kidins220 and endogenous Rab5
in neurons treated with NMDA for the indicated times. Nuclei were stained with DAPI. Merge confocal microscopy images and magnifications
corresponding to the boxed areas are depicted. Scale bar: 10 μm. b, c Percentage of cells displaying colocalization of Kidins220 and Rab5 and mean
Pearson correlation coefficient (PCC) values, respectively, calculated in single optical sections obtained from the different conditions. Data shown are
the means ± s.e.m of three independent experiments after counting n= 20–30 neurons. d Neurons transfected with Rab5-GFP were treated with
NMDA for different times and Kidins220 colocalization was assessed by immunostaining and confocal microscopy. e, f Colocalization of Kidins220
and Rab5-GFP was evaluated by calculating in single optical sections the percentage of cells displaying colocalization and establishing the mean PCC
values. Data shown are the means ± s.e.m of three independent experiments after counting n= 10–15 neurons. **p < 0.01, ***p < 0.001, Student’s t-
test
Fig. 5 NMDAR overstimulation induces a transient activation of Rap1 and ERK. a Rap1 activation curve in response to NMDAR-overstimulation
was determined after pulling down active Rap1-GTP with GST-Ral-GDS and immunoblot analysis. b The amount of active Rap1-GTP in the pull-down
was normalized to total Rap levels present in the lysates and represented relative to the value obtained in nonstimulated cells, arbitrary assigned a
value of 1. Results shown are the means ± s.e.m. of five independent experiments. c ERK activation was measured by immunoblot analysis of
neuronal cultures stimulated with NMDA for various periods of time. d Quantitation of phospho-ERK-1 (pERK-1) and phospho-ERK-2 (pERK-2) levels
with time of NMDA treatment normalized to those of total ERK. Values are expressed relative to those found in untreated cells, arbitrary assigned a
value of 1. Data represented are the means ± s.e.m. of five independent experiments. *p < 0.05, **p < 0.01 and ***p < 0.001, Student’s t-test
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control sequence (ShC), and performed pull-down assays
to determine Rap1 activity (Fig. 6g). Importantly,
Kidins220 silencing blocked NMDA-induced Rap1
activation at 1 h of NMDA treatment, demonstrating that
Kidins220 is necessary for an effective activation of Rap1.
The absence of Rap1-GTP in ShK transduced neurons
Fig. 6 (See legend on next page.)
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was accompanied by reduced levels of p-ERK-1/2,
strongly suggesting that excitotoxic activation of Rap1
downstream Kidins220 is governing ERK activity.
Rap1 regulates ERK activity in excitotoxicity
To establish whether Rap1 may regulate ERK activity
during excitotoxicity, we used the Rap1 inhibitor
GGTI289 and found that this compound reduced ERK-1/
2 activation in response to 10 min and 1 h of NMDA
stimulation (Fig. 7a, b). Additionally, we cloned the con-
stitutively active Rap1A mutant (HA-Rap1A-V12) in a
lentiviral vector under the control of the human Synapsin
promoter for its neurospecific expression20. Immunoblot
analysis of neurons transduced with HA-Rap1A-V12 or
control lentivirus showed that constitutive Rap1 activa-
tion increased phosphorylated ERK-1/2 in the presence of
(see figure on previous page)
Fig. 6 Rap1 translocates to the Golgi apparatus during excitotoxicity and Kidins220 is required for its activation. a Endogenous Rap1 and
GM130 colocalization in NMDA-stimulated neurons was analyzed by immunostaining. Nuclei were stained with DAPI. Merge confocal microscopy
images are shown. Scale bar: 10 μm. b Membrane fractions obtained from DIV14 cortical neurons untreated or treated with NMDA for 30 min were
subjected to ultracentrifugation in a discontinuous Optiprep gradient. Top and bottom fractions of the gradient, together with the different
interfaces (I1–I4), were analyzed by immunoblot with the indicated antibodies. c, d Neurons were cotransfected with Golgi protein mannosidase II
fused to GFP (Golgi-GFP) together with a HA-tagged form of wild-type Rap1A (HA-Rap1A) or its constitutively active form (HA-Rap1A-V12),
respectively. The effect of NMDA treatment on the subcellular distribution of transfected Rap1A forms and its overlapping with Golgi-GFP was
evaluated by immunofluorescence using an antibody against its HA epitope. Merge confocal microscopy images are shown. Scale bar: 10 μm. e, f
Colocalization of Golgi-GFP and HA-Rap1A or HA-Rap1A-V12 was evaluated by calculating the percentage of cells displaying colocalization in single
optical sections and establishing the mean Pearson correlation coefficient (PCC) values. Data shown are the means ± s.e.m of five independent
experiments after counting n= 10–20 neurons. *p < 0.05 and ***p < 0.001, Student’s t-test. g Cortical neurons transduced for seven days with
lentivirus bearing a shRNA for Kidins220 silencing (ShK) or control (ShC) were treated for 1 h with NMDA. Rap1 activity was analyzed by pull-down
assays and immunobloting. Kidins220 interference, pERK-1/2 and total ERK levels were also detected. Neuronal specific enolase (NSE) was used as
loading control. A representative result out of three independent experiments is shown
Fig. 7 Excitotoxic activation of Rap1 contributes to ERK-1/2 activation. a Cortical cultures were incubated 1 h with Rap1 inhibitor GGTI289 (GGTI,
10 μM) prior to NMDA stimulation for the indicated times. Kidins220, Rap1, and ERK-1/2 were analyzed by immunoblotting. b Quantification of pERK-
1 and pERK-2 levels after normalization with those for total ERK. Results are expressed relative to values found in untreated cells, arbitrary assigned a
value of 1. Data represented are the means ± s.e.m. of three independent experiments. c Cortical cultures transduced with control or HA-Rap1A-V12
lentiviruses were treated with NMDA for the indicated times and ERK-1/2 activation was assessed by immunoblot. HA, Rap1, and total ERK-1/2 signals
were also determined. d pERK-1 and pERK-2 levels were normalized to those of total ERK and represented relative to values found in untreated cells,
arbitrary assigned a value of 1. Data represented are the means ± s.e.m. of three independent experiments. *p < 0.05, **p < 0.01, and ***p < 0.001,
Student’s t-test
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NMDA at short times of NMDA treatment, and slightly
delayed ERK inactivation at later times of excitotoxicity
(Fig. 7c, d).
Calpain-dependent degradation of Kidins220/PDZ-GEF1/S-
SCAM Rap1-activation complexes at later times of
excitotoxicity
The temporal coincidence of Kidins220 downregulation
and Rap1 inactivation at later times of excitotoxicity drove
us to examine the effects of NMDA treatment in Rap1-
activation complexes. We analyzed complexes involved in
Rap1 activation downstream neurotrophin receptor and
Kidins220 signaling, such as the one constituted by the
Postsynaptic density-95, Disc Large Zonula occludens
(PDZ) proteins S-SCAM, and PDZ-GEF1 or that formed
by CrkL/C3G22,25,26. The activator of Rap1 PDZ-GEF1
decreased >80% in just 2 h of NMDA treatment (Fig. 8a,
b). The simultaneous appearance of two PDZ-GEF1
fragments of 160 and 80 kDa (Nt-160 and Nt-80), recog-
nized by an N-terminal antibody, suggested that Nt-80
might generate by Nt-160 proteolysis (Fig. 8a, b). In
contrast Rap1 activator C3G and Ras activator SOS were
not modified by excitotoxicity (Fig. 8a). Importantly, the
different isoforms of the adaptor PDZ-protein S-SCAM
(α-S-SCAM, β-S-SCAM, γ-S-SCAM) were progressively
downregulated by NMDA (Fig. 8c, d). No response was
observed for α-syntrophin (Fig. 8c), another PDZ protein
that similarly to S-SCAM interacts with both
NMDARs31–33 and Kidins22026,34, or other adaptor pro-
teins such as Crk and FRS2, or Grb2 and Shc, respectively
involved in Rap122,25,35–37 and Ras38 activation (Fig. 8c).
Antagonist DL-AP5 preincubation confirmed that
NMDAR overactivation was involved in PDZ-GEF1 and
S-SCAM downregulation (Supplementary Fig. 5A, B).
Together, these data demonstrate that excitotoxicity
specifically targets Kidins220, PDZ-GEF1 and S-SCAM to
degradation, and strongly suggest the existence of
Kidins220/PDZ-GEF1/S-SCAM Rap1-activation com-
plexes at early times of excitotoxicity when Rap1 activity
is maximum. Co-immunoprecipitation assays confirmed
that full-length PDZ-GEF1 was associated with S-SCAM
in control and NMDA-treated cells (Fig. 8e), in agreement
with previous data describing that these molecules form a
binary complex independently of the presence of a sti-
mulus26,39. Similarly, Kidins220 was present in S-SCAM
immunocomplexes in both conditions, demonstrating
that the basal interaction of these proteins is maintained
at early times of excitotoxicity (Fig. 8e).
The activity of calpain protease, heavily induced by
NMDAR overstimulation, plays a major role in excito-
toxicity by processing several substrates40,41, including
GluN2 subunits18,42 and Kidins22016,17. By in vitro
digestion of neuronal extracts with purified calpain, we
established that PDZ-GEF1 and S-SCAM are novel
substrates of this protease (Supplementary Fig. 5C, D).
We also demonstrated that PDZ-GEF1 and S-SCAM
downregulation depends on excitotoxic calpain activation
since the specific calpain inhibitor CiIII (10 µM) pre-
vented the decrease of both proteins as it did with
Kidins220 (Fig. 8f). Other protease inhibitors such as the
pan-caspase inhibitor zVAD (100 µM) or the proteasome
inhibitor lactacystin (Lact; 20 µM) exerted no effect (Fig.
8f). These data demonstrate that prolonged excitotoxic
stimulation of NMDARs triggers calpain activation and
processing of Kidins220, S-SCAM, and PDZ-GEF1, all
components of a complex involved in Rap1 activation.
The combined downregulation of these proteins would
precede and be responsible for Rap1 inactivation, con-
tributing to ERK inactivation and neuronal death (see
model in Fig. 8g).
Discussion
Here we show that excitotoxicity induces the traffic of
Kidins220 and GluN1 to the GA through a Rab5-
endocytic compartment at early times of excitotoxicity
in primary neurons (Fig. 8g). Targeting of Kidins220 to
the GA precedes extensive degradation of this molecule
by Ca2+-dependent calpain activation, which starts to be
significant after 2 h of NMDAR overstimulation16. These
data suggest that Kidins220 excitotoxic proteolysis might
take place primarily once it gets to the GA. Among other
subcellular locations, calpains are tightly bound to GA
membranes facing the cytosol together with their endo-
genous inhibitor calpastatin43–45. Excitotoxic calpain
activation has been associated to calpastatin processing46.
Possibly, calpastatin is GA-bound and inhibits calpain
under basal conditions (Fig. 8g). However, intracellular
Ca2+ increases induced by excitotoxicity could trigger
partial calpain activation, sufficient to promote calpastatin
degradation and full protease activation, followed by
proteolysis of cargos at the GA such as Kidins220. This
pathway could serve as a general mechanism for excito-
toxic downregulation of other endocytosed cargos.
Bringing calpain substrates to where calpain is located
constitutes a novel mechanism by which active calpains
could reach their substrates.
We find that active forms of Rap1 bind to GA at early
time-points of excitotoxicity, in accordance with data
describing Rap1 and active Rap1A-V12 association to the
GA in nonneuronal cell lines47–50 and translocation of
Rap1 activator PDZ-GEF1 to perinuclear compart-
ments51. We have observed Rap1 maximal activity at
time-points when Kidins220 has already been recruited to
the GA. Since Rap1 excitotoxic activation depends on
Kidins220, our data support that Rap1 gets activated as
Kidins220 is recruited to this organelle. At later times of
excitotoxicity, calpain activation at the GA would be
responsible for Rap1 inactivation through combined
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proteolysis of the Rap1-activation complex Kidins220/S-
SCAM/PDZ-GEF1 (Fig. 8g). Given that excitotoxicity
does not downregulate other Rap1-activation complexes
(such as C3G, CrkL or FRS2), the cleavage of Kidins220/
S-SCAM/PDZ-GEF1 could be considered as a highly
specific mechanism promoting Rap1 excitotoxic
inactivation.
Downregulation of Rap1 activation complexes by exci-
totoxicity will be ultimately connected to decreases in
ERK activity and neuronal death (Fig. 8g). Physiological
stimulation of NMDARs in neurons activates the ERK
survival pathway3,52. Interestingly, we show here that
excitotoxicity initially tends to activate Rap1/ERK cascade
in response to NMDAR agonist binding, similarly to
physiological conditions. By contrast, excessive NMDAR
activation renders the opposite final outcome after Ca2+
overload and calpain activation, targeting Rap1/ERK
activating components for degradation. It is well accepted
that neurons try to re-enter the cell cycle in response to
toxic glutamate concentrations, resulting in a frustrated
survival mechanism that compromises neuronal viabi-
lity53,54. Indeed, NMDARs overactivation triggers a cell
cycle re-entry in neurons that does not proceed and is
associated to death55. Several evidences support that
glutamate, NMDARs, Kidins220, and Rap1/ERK pathways
participate in the induction of cell cycle re-entry and
proliferation. Glutamate and its receptors facilitate neural
stem cell division as well as that of malignant gliomas, a
type of tumors where Rap1 and ERK activities promote
proliferation56–59. By contrast, NMDARs antagonists
inhibit ERK signaling and supress cancer growth60,61.
Accordingly, NMDAR blockade in developing rodent
brain leads to apoptotic neuronal death62,63. In addition,
Kidins220 is important for cellular survival but also for
proliferation (reviewed in reference 64). Thus, degradation
of Kidins220/Rap1/ERK activation complexes in neurons
identified herein could also contribute to stop pro-cell
division signals triggered through NMDARs during
excitotoxicity.
In addition to NMDARs, Kidins220 also interacts with
tropomyosin-related kinase (Trk) receptors15, being obli-
gatory for neurotrophin-sustained Rap1/ERK activation in
neural cells22,25,26. Our data support that Kidins220 also
controls Rap1/ERK signaling cascade downstream over-
activated NMDARs, exerting a conserved role to that
played downstream of TrkB. Alternatively, Kidins220
could be an effector of both NMDARs and TrkB in a
common pathway preserving neuronal survival. Remark-
ably, TrkB is also downregulated during excitotoxi-
city65,66. Thus, excitotoxic stimulation of NMDARs would
shut off this prosurvival cascade by degrading key acti-
vating molecules including NMDARs18,19, TrkB65,66,
Kidins22016,17, and other members of the Rap1 activation
complexes identified here. Globally, these changes would
contribute to excitotoxic neuronal death.
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Fig. 8 The components of Rap1 activation complexes S-SCAM and PDZ-GEF1 are downregulated during excitotoxicity by calpain-
dependent mechanisms. a Immunoblot analysis of neuronal cultures stimulated with NMDA for various periods of time using antibodies for PDZ-
GEF1 and the indicated proteins. Full-length PDZ-GEF1 (FL) and its derived N-terminal fragments (Nt-160 and Nt-80) are indicated (black arrowheads).
b Levels of FL and Nt-80 PDZ-GEF1 were normalized to those of NSE and expressed relative to values found in untreated cells, arbitrary assigned a
value of 100% (FL) or 0% (Nt-80). Data represented are the means ± s.e.m. of four independent experiments. *p < 0.05, Student’s t-test. c Immunoblot
analysis of neuronal cultures stimulated with NMDA for various periods of time using antibodies for S-SCAM and the indicated proteins. d
Quantification of different S-SCAM isoforms levels normalized to those of NSE and expressed relative to values found in untreated cells, arbitrary
assigned a value of 100%. Data represented are the means ± s.e.m. of four independent experiments. *p < 0.05 and **p < 0.01, Student’s t-test. e S-
SCAM immunoprecipitation (ip) from untreated or 1 h NMDA-treated neurons performed to detect Kidins220, PDZ-GEF1, and S-SCAM association.
The asterisk (*) designates a nonspecific band. f Immunoblot analysis showing the effect of inhibitors specific for calpain (calpain inhibitor III, CiIII,
20 µM), capases (Z-VAD, 100 µM) or the proteasome (lactacystin, Lact, 15 µM) on PDZ-GEF1 and S-SCAM processing induced in excitotoxicity.
Neuronal cultures were incubated with protease inhibitors for 1 h before addition of NMDAR co-agonists. Inhibitors were present for the duration of
NMDA treatment. Reduced cleavage of the calpain substrate spectrin into breakdown products (BDPs) demonstrates the efficiency of calpain
inhibition. g Model of Kidins220 recruitment to the GA and Rap1/ERK activation/inactivation response to excitotoxicity. Kidins220 forms complexes at
the neuronal surface with NMDARs (1). At early times of excitotoxicity Kidins220 is targeted to the GA through a Rab5-positive endocytic
compartment (2). During this phase, Kidins220 acts as an essential component of Rap1 activation complexes (Kidins220/PDZ-GEF1/S-SCAM) (3),
participating in Rap1 activation (4) and the subsequent stimulation of ERK-1/2 (5). At later times of excitotoxicity, the increase in intracellular Ca2+
induced by NMDARs overstimulation could lead to partial activation of Golgi-associated calpain, the cleavage of its inhibitor calpastatin (6), and full
enhancement of calpain proteolytic activity. Activated calpain will then process cargos such as Kidins220 (7), and other components of Rap1
activation complexes, PDZ-GEF1 and S-SCAM (8) associated to the GA. Thereby, late excitotoxicity turns off Rap1/ERK cascade (9), thus compromising
neuronal survival
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